Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast, in anticipation of a potential ...

Thermo Fisher Scientific shares rose Wednesday after the lab equipment and life science solutions firm reported first-quarter ...

Thermo Fisher cut its 2025 EPS and revenue outlook due to tariffs and U.S. policy changes, expecting a $400 million sales hit ...

Thermo Fisher Scientific’s proposal to build a new corporate aircraft hangar and office at Pease in Portsmouth gains approval ...

Company management said they expect the tariff battle with China to cause weakening of $375 million in adjusted operating income.

Goldman Sachs analyst Matthew Sykes lowered the firm’s price target on Thermo Fisher (TMO) to $610 from $670 but keeps a Buy rating on the ...

Thermo Fisher CEO Marc Casper noted strong performance in Q1 2025, delivering $10.36 billion in revenue. Adjusted EPS grew 1% to $5.15. Adjusted operating income was $2.27 billion, with an adjusted ...

Peer Danaher also beat first-quarter profit estimate on better-than-expected demand for its respiratory testing kits. Thermo ...

Thermo Fisher Scientific TMO has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...

Shares of Thermo Fisher Scientific Inc. (TMO) were in the spotlight on Wednesday after the company reported upbeat ...

Thermo Fisher Scientific Inc. closed 25.14% short of its 52-week high of $627.88, which the company achieved on September 10th.